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Even though it is increasingly evident that post-transcrip-
tional events likemRNA processing and splicingmay regulate
gene expression and proteome diversity of malaria parasite Plas-
modium, molecularmechanisms that regulate events likemRNA
splicing inmalaria parasite are poorly understood. Protein ki-
nases control a wide variety of cellular events in almost all eu-
karyotes, includingmodulation ofmRNA splicing, transport, and
stability.We have identified a novel splicing-related protein ki-
nase from Plasmodium falciparum, PfSRPK1. PfSRPK1when
incubated with parasite nuclear extracts inhibited RNA splicing,
suggesting that it may control mRNA splicing in the parasite.
PfSR1, a putative splicing factor from P. falciparum, was identi-
fied as a substrate of PfSRPK1. PfSR1 interacts with RNA and
PfSRPK1modulates its RNA binding. Early in the parasite devel-
opment, PfSRPK1 and PfSR1 are present in the nucleus. These
studies provide useful insights into the function of two potentially
key components of P. falciparummRNA splicingmachinery.
Malaria is one of the most serious infectious diseases and
causes several million deaths and clinical illness in hundreds
of millions of people every year (1). One of the major prob-
lems of recent times has been the emergence of new drug-
resistant strains of the malaria parasite Plasmodium falcipa-
rum. After invasion of the erythrocytes, the parasite can
propagate asexually, giving rise to several new merozoites that
invade fresh erythrocytes, which serve as hosts for the parasite
to propagate. The blood stage infection is the cause of malaria
pathogenesis. The parasite also undergoes sexual differentia-
tion, which leads to the formation of male and female game-
tocytes. Upon ingestion of gametocytes by the Anopheles
mosquito, further development continues inside the vector
host. It is well known that signal transduction events medi-
ated by protein kinases regulate diverse cellular processes.
The importance of protein kinases in malaria parasite has
been highlighted by a series of recent reports (2, 3), as these
enzymes have been implicated in wide ranging events in both
asexual and sexual stages of the parasite life cycle and, there-
fore, are considered as potential drug targets. Despite these
reports, the information regarding signaling networks in the
parasite is very limited.
Although it is clear that metazoan protein kinase cascades
control gene expression by regulating transcriptional or post-
transcriptional events, this area in P. falciparum biology is
largely unexplored. Plasmodium displays a high degree of de-
velopmental control of gene expression (4). Strikingly, only a
few transcription factors have been identified in the parasite
leading to the speculation that post-transcriptional events
may be pivotal in regulating gene expression in the parasite
(5). Translational repression of some genes (6) and control of
gene expression by antisense RNA are some of the post-tran-
scriptional (7) events that have been implicated in regulating
gene expression in the parasite. mRNA splicing is one of the
major regulatory mechanisms that can modulate the expres-
sion of RNA transcripts and facilitate the synthesis of struc-
turally and functionally distinct protein isoforms in most eu-
karyotes. Alternative mRNA splicing, which can cause
proteome diversification from limited number of genes, has
been observed for several Plasmodium genes that may affect
the protein function (8–10). For instance, alternative splicing of
MAEBL results in generation of different forms (9, 11). One of its
isoforms, which has a transmembrane domain, is essential for
invasion of mosquito salivary glands (11). The alternative splic-
ing-mediated generation of protein isoforms can be one of the
means via which the parasite may evade strategies devised to
curb it. The knowledge of post-transcriptional mechanisms like
mRNA splicing in Plasmodium is very limited (12, 13).
Typically, mRNA splicing occurs in the nucleus where the
processed mRNA is stabilized and is exported to the cyto-
plasm for translation. Pre-mRNA splicing in mammalian cells
is mediated by a multicomponent complex known as the spli-
ceosome, which contains two classes of splicing factors; that
is, small nuclear ribonucleoprotein particles (snRNPs) and
non-snRNP splicing factors (14, 15). A series of interactions
between pre-mRNA and small nuclear ribonucleoprotein par-
ticles during spliceosome assembly is critical for splice-site
selection and, importantly, for establishing a catalytic core for
the splicing reaction to occur in the spliceosome. Among the
best characterized non-snRNP factors is the superfamily of
arginine/serine-rich (RS)5 domain-containing splicing factors
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(14). SR proteins are critical components of the spliceosome
that influence both constitutive and alternative splicing of
pre-mRNA. SR protein function is regulated by phosphoryla-
tion of their RS domains by multiple kinases, including a fam-
ily of evolutionarily conserved SR protein-specific kinases
(SRPKs). The SRPK family of kinases is unique as the kinases
are capable of phosphorylating repetitive RS domains with
remarkable specificity and efficiency (16, 17). In mammals
and yeast, SRPKs have been implicated in several key func-
tions like regulation of mRNA processing, nuclear import,
germ line development, polyamine transport, and ion homeo-
stasis (18–20). In addition to SRPKs, SR proteins are also
phosphorylated by cdc28/cdc2-like kinases (Clk/Sty) (17). The
cooperative phosphorylation of SR proteins is considered im-
portant for modulating its function and cellular localization
(19). While cloning and identification of a Clk/Sty family
member PfLAMMER has been reported (21), the regulation
of SRPKs or Clk/Sty-like kinases is unexplored in
P. falciparum.
We have identified and characterized a SRPK (PfSRPK1)
and a splicing factor (PfSR1) in P. falciparum. PfSRPK1 phos-
phorylates PfSR1 and has the ability to modulate RNA
splicing.
EXPERIMENTAL PROCEDURES
P. falciparum Cultures—P. falciparum 3D7 strain was cul-
tured at 37 °C in RPMI 1640 medium using either AB hu-
man serum or 10% Albumax II (Invitrogen) as previously de-
scribed (22). Synchronization of the parasites in culture was
achieved by sorbitol treatment as reported earlier (23), and
gametocytes were obtained as described previously (24).
In Silico Studies and Molecular Cloning of PfSRPK and
PfSR Genes—A BLAST search was performed against the
P. falciparum data base (PlasmoDB) using sequences for
human SRPK1 (accession number NP_003128) and human
SF2/ASF (accession number NP_008855). Two P. falcipa-
rum kinases (PFC0105w and PFl4_0408) that possess features
of SRPKs emerged as orthologues of SRPKs and were named
PfSRPK1 and PfSRPK2, respectively. PFE0160c, which exhib-
ited homology to human SR protein SF2/ASF and possessed
two RNA recognition motifs and an RS domain, was named as
splicing factor PfSR1. The sequence information obtained for
these genes from PlasmoDB was used to design PCR primers
(supplemental Table S1). The kinase domain of PfSRPK1 and
full-length PfSR1 was amplified by RT-PCR. Total RNA was
isolated from asynchronous P. falciparum 3D7 cultures, and
reverse transcription was performed using random hexamers
provided in the Thermoscript reverse transcription-PCR kit
(Invitrogen). Complimentary or genomic DNA was used as a
template for PCR reactions, which were performed using plat-
inum Taq polymerase (Invitrogen). Typically, after cycling
parameters were used for these reactions: 94 °C for 2 min ini-
tial denaturation followed by 30 cycles at 94 °C for 30 s, 45 °C
for 30 s, 68 °C for 2 min, and a final extension at 68 °C for 10
min. PfSRPK1_K89M was generated by overlapping PCR
mutagenesis using primer sets K89M_F and K89M_R (supple-
mental Table S1).
Expression and Purification of Recombinant Proteins—The
kinase domain (KD) of PfSRPK1 is split in two segments (KDI
and KDII), which are separated by a spacer region. The PfS-
RPK1 kinase domain without the spacer region, PfSRPK1,
was expressed as a recombinant protein. To achieve this, ki-
nase domain I (KDI) and kinase domain II (KDII) of PfSRPK1
were amplified by RT-PCR using primers (PfSRPKF2/PfSR-
PKR2 and PfSRPKF3/PfSRPKR3) containing overhangs for
SacI/HindIII and HindIII/XhoI restriction enzymes, respec-
tively. The two PCR products were ligated and subsequently
cloned in pET28 vector. Using this construct as a template,
PfSRPK1 was cloned in SmaI and NotI sites of pGEX-4T3
vector (Amersham Biosciences) to facilitate its expression as a
GST fusion protein. PfSR1 was amplified using primers
(PfSR1F1/PfSR1R1 and PfSR1F2/PfSR1R2) with overhangs for
SacI/HindIII and BamHI/NotI for cloning in pET28 and
pGEX4T3 vectors, respectively. Human ASF/SF2 was cloned
in BamHI and XhoI sites in pGEX4T3 vector. Escherichia coli
BL21-DE3 strain was transformed with pET28 plasmids, and
BL21-RIL strain was used with pGEX4T3 plasmids. Bacterial
cultures were grown in LB media containing either 25 g/ml
kanamycin or 100 g/ml ampicillin and 25 g/ml chloram-
phenicol. When cultures were in mid-logarithmic phase, ex-
pression of proteins was induced by 1 mM isopropyl -D-1-
thiogalactopyranoside at 18 °C for 14 h. Bacterial cells were
harvested by centrifugation at 4000 g for 30 min suspended
in cold lysis buffer (50 mM Tris, pH 7.4, 2 mM EDTA, 1 mM
dithiothreitol, 1% Triton X-100, and protease inhibitor mix-
ture (Roche Applied Science), and sonication was performed
for 6 cycles of 1 min each. The resulting cell debris was re-
moved by centrifugation at 20,000 g for 40 min at 4 °C. Fu-
sion proteins from the cell lysates were affinity-purified using
glutathione-Sepharose resin as described previously (22, 25).
Briefly, the resin was washed with lysis buffer, and bound pro-
teins were eluted with 50 mM Tris, pH 8.0, with 10 mM gluta-
thione. Finally, purified proteins were dialyzed against 50 mM
Tris, pH 7.4, 1 mM dithiothreitol, and 10% glycerol. Protein
concentration was determined by densitometry analysis of
Coomassie-stained gels. The recombinant His6-PfSR1 protein
was solubilized in extraction buffer (50 mM Tris, pH 7.4, 300
mM NaCl, and 8 M urea), and the clarified lysate was incu-
bated with nickel nickel-nitrilotriacetic acid-agarose (Qiagen)
with end-to-end shaking for 3 h at room temperature. The
resin was poured into a column, washed with extraction
buffer, and eluted with extraction buffer containing 0.5–10
mM imidazole. Fractions containing the protein of interest
were pooled and dialyzed against buffers containing decreas-
ing amounts of urea (25 mM Tris, pH 7.4, 150 mM NaCl, 1 mM
dithiothreitol, 0–6 M urea) to refold the recombinant protein.
Recombinant proteins were estimated and analyzed by
densitometry.
Immunoblotting, Immunofluorescence, and
Immunoprecipitation—Polyclonal anti-PfSRPK1 serum was
raised in rabbits using a synthetic peptide designed from the
C-terminal sequence (NVNKINCKVINKKNS). This peptide
was conjugated to keyhole limpet hemocyanin via an addi-
tional N-terminal cysteine residue (Peptron Inc.). Antiserum
against PfSR1 was raised in mice using purified recombinant
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GST-PfSR1 protein. Anti-GST antibodies were depleted by
incubating the antisera with GST as described previously (26).
For immunoblotting experiments, parasites were released
from infected erythrocytes by 0.1% (w/v) saponin treatment.
Cell-free protein extracts were prepared by suspending para-
site pellets in a buffer containing 10 mM Tris, pH 7.5, 100 mM
NaCl, 5 mM EDTA, 1% Triton X-100, and 1 Complete Pro-
tease inhibitor mixture (Roche Applied Science) using a sy-
ringe and a needle. Lysates were cleared by centrifugation at
14,000 g for 30 min. After separation of lysate proteins on
SDS-PAGE gels, proteins were transferred to a nitrocellulose
membrane. Immunoblotting was performed using anti-PfS-
RPK1 and anti-PfSR1 antisera and horseradish peroxidase-
labeled anti-rabbit IgG, and West Pico enhanced chemilumi-
nescence substrate (Pierce) was used to develop the blots.
PfSRPK1 was immunoprecipitated from parasite lysates using
anti-SRPK1 antisera. For this purpose, erythrocyte-free para-
site lysates were prepared as described above except phospha-
tase inhibitors (20 M sodium fluoride, 20 M-glycerophos-
phate, and 100 M sodium vanadate) were added to the lysis
buffer. 100 g of lysate were incubated with the anti-sera at
4 °C overnight on an end-to-end shaker. Subsequently, anti-
gen-antibody complexes were incubated with 50 l of protein
A-Sepharose beads for 2 h with end-to-end shaking. After
washing with PBS several times, beads were finally resus-
pended in 50 l of kinase assay buffer containing phosphatase
inhibitors.
Immunofluorescence assays were performed on parasite
smears fixed with methanol or acetone as described previ-
ously (27, 28). Briefly, smears were blocked in phosphate-buff-
ered saline containing 0.05% saponin and 5% bovine serum
albumin. Subsequently, incubation with primary antisera was
performed for 2 h at room temperature or at 4 °C overnight
followed by incubations with anti-mouse IgG labeled with
Alexa 488 or Alexa 544 and 4,6-diamidino-2-phenylindole
(DAPI), which was used to stain parasite nucleus. The para-
sites were visualized using either a Zeiss Axio Imager fluores-
cence microscope, and images were processed using Adobe
Photoshop or Axiovision software.
In Vitro Kinase Assays—Recombinant GST-PfSRPK1 was
assayed for catalytic activity in a buffer containing 50 mM
Tris, pH 7.5, 10 mM magnesium chloride, 1 mM dithiothre-
itol, and 100 M [-32P]ATP (6000 Ci/mmol) using GST-
PfSR1, His6-PfSR1, and GST-ASF/SF2 proteins and RS pep-
tide as phosphate-acceptor substrates. The RS peptide
(RSPSYGRSRSRSRSRSRSRSRSNSRSRSY) was synthesized by
Peptron Inc. Typically, reactions were carried out for 20–60
min at 30 °C and terminated by boiling the samples in SDS-
PAGE sample buffer when proteins were used as phosphoac-
ceptor substrates. Subsequently, reaction mixtures were elec-
trophoresed on SDS-PAGE gel followed by autoradiography
to visualize phosphate incorporation in the substrates. When
RS peptide was used as the phosphor-acceptor substrate, re-
actions were stopped by spotting the samples on P11 phos-
phocellulose paper followed by washing the paper strips with
75 mM orthophosphoric acid. Phosphate incorporation was
assessed by scintillation or Cerenkov counting of the P11
paper.
RNA Splicing Reactions—The 3-end of PF13_0082 gene
(cop-coated vesicle membrane protein p24 precursor, puta-
tive) consisting of exon 3 (174 bp), intron 3 (133 bp) and exon
4 (189 bp) was cloned in pGEMT easy, and the plasmid was
linearized with NdeI. 1 g of linearized plasmid DNA was
used to generate radiolabeled RNA transcripts using RiboMax
kit (Promega) and 50 Ci of [-32P]UTP (3000 Ci/mmol;
PerkinElmer Life Sciences) following the manufacturer’s in-
structions. Splicing of the purified RNA transcript was carried
out in 50% v/v P. falciparum nuclear extracts, which were pre-
pared by following a previously published protocol (29).
Briefly, parasite pellets (obtained from 200 ml culture, 10%
parasitemia) were incubated for 5 min in ice-cold lysis buffer
(20 mM HEPES, pH 7.8, 10 mM KCl, 1 mM EDTA, and 1 mM
DTT, 1 mM PMSF, 1% Nonidet P-40) and centrifuged at
2500 g for 5 min at 4 °C. The pellet-containing nuclear frac-
tion was washed twice with lysis buffer and centrifuged at
2500 g for 5 min at 4 °C, resuspended in extraction buffer
(20 mM HEPES, pH 7.8, 0.4 M NaCl, 1mM EDTA, 1 mM EGTA,
1 mM DTT, protease inhibitors), and incubated on ice for 15
min with vigorous shaking every 3 min. The lysate obtained
after centrifugation was dialyzed against a buffer containing
20 mM HEPES, 0.2 mM EDTA, 50 mM KCl, 20% glycerol, 0.5
mM DTT, 2 mM PMSF). The in vitro transcribed 488-bp frag-
ment of PF13_0082 pre-mRNA was incubated with intact or
boiled nuclear extracts in the presence or absence of bacterially
expressedPfSRPK1 for 30min at 25 °C (supplemental Fig. 6) in
a reactionmix that contained 2mMATP, 2.5 mMMgCl2, 3%
PEG 8000, 0.6 M KH2PO4, RNasein nuclear extract 50% (v/v),
radiolabeled RNA (40,000 cpm). On completion of splicing reac-
tions, mixtures were treated with proteinase K (50mg/ml), ex-
tracted with TRIzol, and precipitated with ethanol. RNAwas
fractionated by denaturing 5% PAGE, and splicing products were
visualized by autoradiography (30).
UV Cross-linking of RNA and Protein—32P-Labeled RNA
transcript was prepared as described above. Recombinant
proteins GST or GST-PfSR1 was incubated with labeled RNA
in binding buffer (14 mM HEPES, pH 7.5, 6 mM Tris-Cl, pH
7.5, 1 mM EDTA, 1 mM DTT, and 60 mM KCl) for 30 min at
30 °C. The reaction mixture was transferred to an ice bath and
irradiated with a short wavelength (254 nm) UV lamp (4 watt)
held at a 3-cm distance from the reaction mixture for 30 min.
After irradiation, RNase (2.5 units) was added, and the reac-
tion mixture was incubated for 30 min at 37 °C to digest un-
bound RNA. The UV cross-linked products were boiled in
Laemmli sample buffer for 3 min and analyzed on a discontin-
uous SDS–10% polyacrylamide gel (acrylamide/bisacrylamide
ratio, 29:1). The gel was fixed with 7% acetic acid, and labeled
complexes were visualized by autoradiography (31).
RESULTS
Identification and Molecular Cloning of Two SRPKs in
P. falciparum—To identify SRPK orthologues in P. falcipa-
rum, human SRPK1 sequence was used to search the P. falci-
parum genome sequence in silico. Two PlasmoDB annotated
gene products PFC0105w and PF14_0408 exhibited45 and
25% sequence homology with the kinase domain of human
SRPK1, respectively. PfSRPK1 has all the kinase subdomains
Regulation of SRPK and SR Proteins inMalaria Parasite
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conserved and also possesses an insertion between domains
VIb and VII, which is a signature for SRPKs (17) (supplemen-
tal Fig. S1). PfSRPK2 exhibited several differences when com-
pared with PfSRPK1 and human SRPK1, most significantly
the lack of glycines in ATP binding pocket (supplemental Fig.
S1). These results agree with previous report on the kinome of
P. falciparum, which predicted PFC0105w and PF14_0408 as
members of SRPK family (2). The studies described here
mainly deal with PfSRPK1 (PFC0105w). The uninterrupted
kinase domain of PfSRPK1, obtained after the removal of the
spacer region (Fig. 1A), was cloned in an expression vector to
facilitate the expression of the recombinant PfSRPK1 in
E. coli (Fig. 1B). GST-PfSRPK1 was able to phosphorylate
myelin basic protein (MBP) in vitro, indicating that this
spacer region-deleted version of the kinase was active (Fig.
1C) as was also the case with human SRPK1 (17). GST-PfS-
RPK1 also exhibited autophosphorylation, which was reduced
in the presence of MBP, most likely due to competition for
the substrate binding site, thus suggesting that PfSRPK1
may undergo trans-autophosphorylation. Most protein ki-
nases possess a lysine near the ATP binding site, which is re-
sponsible for proper orientation of ATP and, therefore, is piv-
otal for catalysis. On comparison with other known protein
kinases, Lys-89 emerged as a putative candidate for perform-
ing similar functions. The mutation of Lys-89 to Met resulted
in loss of PfSRPK1 activity (Fig. 1C, right panel), highlight-
ing the importance of this residue in PfSRPK1 function.
PfSRPK1 Is Active in Constitutive Cis-splicing Reactions—To
study the effect of PfSRPK1 in mRNA splicing, in vitro splic-
ing reactions were performed using P. falciparum nuclear
extracts as the source of splicing machinery. The pre-mRNA
of cop-coated vesicle membrane protein p24 precursor
(PF13_0082) gene was used as a candidate for splicing. This
gene was chosen because it possesses conserved splicing-asso-
ciated sequences at the exon-intron junctions; it has a GU at a
5 splice site at the exon 3-intron 3 junction, adenosine at
branch point, and AG at the 3 splice site of intron 3-exon 4
junction (Fig. 2A and supplemental Fig. S3). The PlasmoDB-
annotated gene structure between exon 3 and 4 was con-
firmed by experimentally determining the cDNA and
genomic DNA sequence. The predicted exon-intron boundary
in this region matched with the experimentally determined
sequence.6 The 488-bp 3-end region of this gene, which con-
tains exons 3 and 4 that span an intron of 131 bp (Fig. 2A),
was in vitro transcribed (supplemental Fig. S3). Incubation of
this radiolabeled transcript with parasite nuclear extracts gen-
erated splicing fragments of the expected size (Fig. 2B, lane 3).
When PfSRPK1 was included in these assays, a significant
6 P. K. Singh and P. Malhotra, unpublished results.
FIGURE 1. PfSRPK1, a SRPK from P. falciparum. A and B, shown is a schematic diagram illustrating the split kinase domain of PfSRPK1 along with the
spacer region. The kinase domain lacking the spacer region, PfSRPK1, was expressed as a GST fusion protein in E. coli (B). C, GST-PfSRPK1 phosphorylates
MBP. Left panel, GST-PfSRPK1 was incubated with (lane 2) or without MBP (lane 1) in a kinase assay mix. Right panel, an equal amount of PfSRPK1 (lane 1)
or its K89Mmutant (lane 2) was incubated with MBP in a kinase assay mix. Phosphate incorporation was monitored by autoradiography of the SDS-PAGE
gel.
FIGURE 2. PfSRPK1modulates mRNA splicing. A, shown is schematic
representation of the PF13_0082 gene with PlasmoDB annotated exons/
introns. Arrows indicate the region of the gene, which was used for in vitro
transcription. B, the radiolabeled PF13_0082 pre-mRNA transcript corre-
sponding to the region indicated in panel A (lane 2) was incubated with par-
asite nuclear extracts (NE) in the absence (lane 3) or presence of 100 ng of
bacterially expressed PfSRPK1 (lane 4) or K89Mmutant (lane 5). Additional
control experiments were performed in the presence of GST protein (lane
1). The reaction mix was separated by PAGE followed by phosphorimaging;
various products were identified on the basis of their molecular size and are
indicated in the figure. Results representative of more than three indepen-
dent experiments are shown in the left panel. Right panel, an experiment
similar to the one described in the left panelwas performed, bands corre-
sponding to the mature and precursor RNA were quantified by densitome-
try, and the ratio of their intensities was plotted. Mean of replicates from
the experiment is shown; error bars represent the S.E.
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inhibition in the formation of the spliced product was ob-
served (Fig. 2B, lane 4). Control experiments performed
with GST protein did not cause an inhibition in splicing
(lane 1). Importantly, the K89M kinase dead mutant of
PfSRPK1 did not cause any significant changes to splicing
(lane 5), suggesting that the observed effects were due to
PfSRPK1 catalytic activity. These studies demonstrate
that PfSRPK1 may participate in mRNA splicing in vitro,
and it has a negative effect on mRNA splicing mediated by
the nuclear extract.
PfSR1, a SR-like Protein, Interacts with RNA—Having estab-
lished that PfSRPK1 may modulate mRNA splicing, we
probed its possible involvement with the components of the
parasite splicing machinery. Typically, SRPKs from other or-
ganisms phosphorylate RS-rich domains in proteins, and of-
ten these domains are found in splicing factors SR proteins.
We scanned the Plasmodium genome using RS domain of
yeast and mammalian splicing factors. PFE0865c, which was
named PfSR1, emerged as a candidate for mRNA splicing fac-
tor as it contained C-terminal RS domains and two RNA rec-
ognition motifs at the N terminus. PfSR1 shared54% se-
quence homology with human splicing factor 2 (ASF/SF2)
(supplemental Fig. S2). PfSR1 cDNA was amplified by per-
forming RT-PCR, and DNA sequencing revealed that the
PfSR1 gene comprises 897 bp that includes a 177-bp intron
(Fig. 3A). PfSR1 contains two RNA recognition motifs with
conserved signature octapeptide (EFEDARDA) and heptapep-
tide (SWQDLKD) sequences (supplemental Fig. S2). A C-
terminal domain with tandem repeats of arginines and serines
(RS domain), which is typical of SR protein family members,
is also present in PfSR1 (Fig. 3A, supplemental Fig. S2). The
ability of PfSR1 to interact with RNA was tested by using re-
combinant GST-PfSR1 (Fig. 3B). For this purpose, P. falcipa-
rum gene PF13_0082 was selected (described above), and the
radiolabeled RNA transcript corresponding to 450 bp seg-
ment of this gene was generated by in vitro transcription/
translation in a cell free system (supplemental Fig. S3). This
RNA transcript exhibited binding to PfSR1 in a UV cross-
linking experiment (Fig. 3C).
PfSRPK1 Phosphorylates PfSR1 and Generates Phospho-
epitopes That Are Different fromHuman SF2—Metabolic label-
ing experiments suggested that PfSR1 is phosphorylated in the
parasite (data not shown).We tested if PfSRPK1 is the candidate
kinase that may perform this function. Incubation of recombi-
nant PfSRPK1 and not the K89Mmutant with recombinant
PfSR1 in a kinase assay resulted in phosphorylation of PfSR1 (Fig.
4A). A peptide corresponding to RS domain of SF2/ASF (RS-
peptide, RSPSYGRSRSRSRSRSRSRSRSNSRSRSY), which was
previously shown to be a substrate of human SRPK1 (32), was
synthesized.PfSRPK1 efficiently phosphorylated the RS pep-
tide (Fig. 4B), suggesting that PfSRPK1 indeed has affinity for the
RS-rich sequences. To further establish this, we expressed a dele-
tionmutant of PfSR1, PfSR1C, that lacked the last 128 amino
acids that contain the RS domain. Although PfSR1 was phos-
phorylated by PfSRPK1, this mutant was not phosphorylated by
the kinase, further suggesting that PfSRPK1 targets the RS
domain of PfSR1 (Fig. 4C).
Previously, it was demonstrated that the hybridoma
mAb104 recognizes phospho-epitopes generated as a result of
phosphorylation of the RS domain of human SF2 by SRPK1
(33). Even though PfSRPK1 phosphorylated PfSR1 (Fig, 4D,
right panel, lane 1), mAb104 failed to recognize the phos-
phorylated form of PfSR1. Interestingly, PfSRPK1 phosphor-
ylated ASF/SF2 and was able to generate mAb104-positive
phospho-epitopes on human SF2/ASF (Fig. 4D, left panel,
lane 1). Close examination of the amino acid sequences of
PfSR1 and SF2/ASF revealed that the distribution pattern
and/or the number of RS repeats in the RS domain of PfSR1 is
different from SF2 (supplemental Fig. S2). The variation in
sequence and RS repeat pattern in two proteins may result in
differential recognition by mAb104. It is also possible that the
RS domains of the two proteins may adopt different confor-
FIGURE 3. PfSR1 is an SR protein that interacts with RNA. A, shown is a schematic diagram illustrating the structure of PfSR1. Top, PfSR1 gene has a single
intron that separates two exons. Bottom, PfSR1 comprises two RNA recognition motifs (RRM1 and RRM2) and an arginine-serine rich (RS) domain. B, PfSR1
was expressed as a GST fusion (left panel) or a His6-tagged (right panel) protein in E. coli and was purified by affinity chromatography. C, GST (lane 1) or GST-
PfSR1 (lane 2) was incubated with radiolabeled RNA transcript for PF13_0082 (see Fig. 2 and supplemental Fig. S3) followed by UV cross-linking. Subse-
quently, RNA bound protein was separated on a SDS-PAGE gel and detected by autoradiography.
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mations after phosphorylation, and mAb104 only recognizes
the phosphorylated form of RS domain of SF2. It will be inter-
esting to see if these variations account for differences in the
mechanisms via which PfSR1 and SF2/ASF may operate in
two different systems.
Association of PfSRPK1 and PfSR1—To evaluate if PfSRPK1
and PfSR1 associate in the parasite, co-immunoprecipitation
experiments were performed. When PfSRPK1 was immuno-
precipitated, PfSR1 was present in its immunoprecipitate (IP)
(Fig. 5A). Recombinant GST-PfSRPK1 and His6-PfSR1 pro-
teins were incubated in vitro, and GST pulldown assays were
performed. The presence of His6-PfSR1 in GST-PfSRPK1-
bound fractions indicated direct association of these proteins
(Fig. 5B). GST by itself did not exhibit any significant binding
to PfSR1. These observations established the interaction be-
tween PfSRPK1 with PfSR1 in vitro and in parasite extracts.
Given the association (Fig. 5, A and B) and phosphorylation
of PfSR1 by PfSRPK1 (Fig. 4A), we next tested the effect of
phosphorylation of PfSR1 on its RNA binding ability. To
achieve this, PfSRPK1-phosphorylated PfSR1 or its unphos-
phorylated form were incubated with the RNA transcript fol-
lowed by cross- linking. The amount of RNA bound to the
phosphorylated PfSR1 was significantly (45%) reduced in
comparison to its unphosphorylated form (Fig. 5C, lane 3 ver-
sus lane 2). These data may help explain PfSRPK1-mediated
inhibition of splicing by the nuclear extracts; it is possible that
the generation of negative charge due to phosphorylation of
the PfSR1-RS domain may disrupt its binding to RNA, which
may influence splicing.
FIGURE 4.PfSRPK1phosphorylates PfSR1.A, recombinant GST-PfSRPK1 (left panel) or its kinase dead K89Mmutant (right panel) was incubatedwith GST-PfSR1
(A) or RS peptide (B) in a kinase assaymix, and the reactionmixturewas separated on a SDS-PAGE gel followed by autoradiography to detect the phosphorylation
of PfSR1 (A). For assessing the phosphorylation of RS peptide (B), the reactionmixwas spotted on a phosphocellulose paper followed by scintillation counting. Re-
sults representative ofmore than three independent experiments are shown in the figure. Themean of replicates from the experiment is shown; error bars repre-
sent the S.E. C, PfSR1C, a C-terminal deletionmutant PfSR1 that lacked the last 128 amino acids of PfSR1 that contained the RS domain, was expressed. Equal
amounts of thismutant (lane 3) or PfSR1were (lane 1) were incubated in a kinase assaymixwithPfSRPK1 followed by SDS-PAGE and autoradiography. Unlike
PfSR1, PfSR1Cwas not phosphorylated by the kinase.D, equal amounts of GST-ASF/SF2 (left panels) or GST-PfSR1 (right panels) were incubatedwith GST-PfS-
RPK1 (lane 1) or K89M (lane 2) in a kinase assaymix, and the phosphorylation reactionwas carried out asmentioned above. The autoradiography of the SDS-PAGE
gel revealed the labeling of phosphorylated proteins. Simultaneously, a similar phosphorylation experimentwas also performed inwhich unlabeled ATPwas used.
In this case the reactionmixwas used forWestern blot (WB), whichwas performed usingmAb104 (middle panel).
FIGURE 5.PfSRPK1 interactswith PfSR1 and influences its interactionwith
RNA. A, immunoprecipitationwas performed using antisera against PfSRPK1 or
pre-immune serum (control). Co-immunoprecipitation (IP) assayswere electro-
phoresed on a SDS-PAGE gel followed byWestern blottingwith anti-PfSR1 anti-
sera. B, equal amounts of His6-PfSR1were incubatedwith GST-PfSRPK1 (lane
2) andGST (lane 1), andGST-pulldown assayswere performed. PfSR1 associated
with GST fusion proteinwas detected byWestern blotting using anti-PfSR1
antisera. C, first, PfSR1was phosphorylated by PfSRPK1 using unlabeled ATP in
a kinase assaymix. In vitro transcribed and radiolabeled RNA transcript for
PF13_0082was incubatedwith either unphosphorylated PfSR1 (ATP) or PfS-
RPK1-phosphorylated PfSR1 (ATP) followed byUV-cross linking (as described
for Fig. 2C) followed by autoradiography of SDS-PAGE gels. RNA-PfSR1 complex
was observed at the expectedmolecular weight. Control experimentwas per-
formedusingGST (lane 4) or GST-PfSRPK1 (lane 1).
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Localization of PfSRPK1 and PfSR1 during Parasite
Development—To establish a connection between PfSRPK1
and PfSR1, their expression pattern in different developmen-
tal stages of the parasites was determined. To achieve this,
antisera was raised against a peptide corresponding to a C-
terminal region of PfSRPK1, which was absent from PfSRPK2.
The Western blot analysis of protein lysates prepared from
different blood stages of the parasite revealed a band of150
kDa (supplemental Fig. S5, Fig. 6A) that was close to the pre-
dicted size of PfSRPK1 protein. In addition, its expression was
also detected in P. falciparum gametocytes (Fig. 6A), which
was consistent with transcriptome data at PlasmoDB. Immu-
noblotting with anti-PfSR1 antisera identified a protein corre-
sponding to the size of PfSR1. Like PfSRPK1, PfSR1 protein
was also found in both asexual parasitic stages as well as ga-
metocytes (Fig. 6A). Control pre-immune antisera from the
same rabbit failed to detect this protein (data not shown).
To determine the cellular localization of PfSRPK1 and
PfSR1, immunofluorescence assays were performed on para-
sites of different life-cycle stages. The staining for PfSR1 and
PfSRPK1 overlapped in all parasitic stages (Fig. 6B). One of
the striking finding of this study was the stage-specific nuclear
trafficking of PfSRPK1 and PfSR1. These proteins were pres-
ent predominantly inside the nucleus in the ring stages as in-
dicated by co-localization with nuclear dye DAPI (Fig. 6B).
PfSRPK1 and PfSR1 were present in the nucleus of75% of
rings and young trophozoites that were analyzed. As the para-
sites matured, PfSRPK1 and PfSR1 seemed to be exported to
nuclear periphery and/or cytoplasm in mature trophozoites.
Both these proteins were predominantly in the cytoplasm of
most (80%) schizonts. Interestingly, both PfSRPK1 and
PfSR1 are present in the cytoplasm of gametocytes with possi-
bly only a small fraction in the nucleus (Fig. 6B). PfSR1 also
appeared to be present on schizont-infected red blood cor-
puscles surface in some parasites (data not shown), although
this needs further evaluation.
The nuclear-cytoplasmic localization was further con-
firmed by performing immunofluorescence assays with a nu-
clear protein PfTSN (supplemental Fig. S4) (34). PfSRPK1
co-localized with this nuclear protein in ring stages; both
these proteins were in the nucleus. Although TSN continued
to be present in the nucleus of trophozoites and schizonts,
PfSRPK1 did not exhibit significant co-localization with it
(supplemental Fig. S4). Furthermore, nuclear and cytoplasmic
proteins were fractionated followed by immunoblotting. PfS-
RPK1 was predominantly in the nucleus of rings and in the
cytoplasm of the mature parasites (Fig. 6C), which was in
agreement with the immunofluorescence assays data.
DISCUSSION
Recent reports suggest that a large number of Plasmodium
genes may undergo constitutive and alternative splicing (8).
However, P. falciparummRNA splicing machinery is still a
“black box.” In the case of higher eukaryotes, protein phos-
phorylation has been shown to play a role in the regulation of
mRNA splicing (17, 35, 36). In the present study we have
characterized PfSRPK1, an SR protein kinase in P. falciparum,
and defined its role in interaction and localization of mRNA
splicing factor PfSR1.
FIGURE 6. Expression and localization of PfSRPK1 and PfSR1 during parasite development. A, PfSRPK1 and PfSR1 are expressed in both asexual and
gametocyte stages of P. falciparum life cycle. Equal amounts of cell lysate prepared from rings (R or Ring), trophozoites (T or Trop), schizonts (S or Schi), and
gametocytes (G) were used for Western blot analysis, which was performed with anti-PfSR1 or anti-PfSRPK1 antisera. PfHSP70 was used as the loading con-
trol. B, immunofluorescence studies were performed on blood smears made from cultures containing parasites of different stages using antisera against
PfSRPK1 (red), PfSR1 (green). Parasite nuclei were stained with DAPI. DIC, differential interference contrast. C, the cytoplasmic (C) and nuclear (N) fractions of
parasite protein lysates prepared from different asexual parasitic stages were used for immunoblotting with PfSRPK1 antibody.
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One of the features of SRPK and SR proteins is their dy-
namic nucleo-cytoplasmic shuttling, which is tightly regulated
by phosphorylation (17, 18). It is known that the phosphoryla-
tion status of the RS domain of SR proteins is a key determin-
ing factor for their nuclear localization (37). In mammalian
cells, SRPK is predominantly present in the cytoplasm, where
it phosphorylates the RS domain of SF2/ASF, which causes its
nuclear translocation (19, 37, 38). In the nucleus, protein
kinase Clk/Sty further phosphorylates SF2/ASF (“hyper-
phosphorylated” form), which results in its release from
nuclear speckles to the site of mRNA splicing. Subse-
quently, it is dephosphorylated by protein phosphatase
PP1, resulting in its export to the cytoplasm (reviewed in
Ref. 19). In comparison to SF2/ASF, SRPK1 spends only a
short time in the nucleus, which is at G2/M transition (39).
We found that PfSRPK1 is predominantly inside the para-
site nucleus during the early stages of development of asex-
ual parasites. After mid-late trophozoite stages, there
seems to be a switch in its localization to the cytoplasm. It
is interesting to note that PfSR1 localization almost always
goes “hand in hand” with that of PfSRPK1. Due to their
interaction, it is possible that PfSRPK1 “piggybacks” PfSR1
in and out of the nucleus or vice versa. In the gametocyte,
PfSRPK1 and PfSR1 were predominantly in the cytoplasm
with some amounts in the nucleus. Given the function of
SRPK and SR proteins in diverse events ranging from
mRNA splicing in the nucleus (14) to translation repres-
sion in the cytoplasm (40), it will be interesting to deter-
mine whether these proteins participate in similar func-
tions in the parasite. Translational repression of certain
mRNA species has been observed in Plasmodium female
gametocyte, which is achieved by storing the mRNA in the
cytoplasm before fertilization (6). Given the presence of
PfSR1 in gametocyte cytoplasm and its RNA binding abil-
ity, it will be worth investigating if PfSR1 and PfSRPK1 play
a role in this process.
Recent reports suggest that the role and extent of mRNA
splicing in Plasmodiummay have been underplayed as a sig-
nificant number of genes undergo splicing (8). To evaluate
the function of PfSRPK1 in mRNA splicing, we selected
gene PF13_0082. P. falciparum nuclear extracts were able
to splice the pre-mRNA transcript for this gene and PfS-
RPK1, effectively blocked the splicing. It is well recognized
that both hyper- and hypo-phosphorylation of SR proteins
differentially effect mRNA splicing (19). SRPK1 and SR
protein homologues have been identified in Trypanosoma
cruzi. Although their direct involvement in the splicing of
T. cruzi mRNA has not been demonstrated, TcSRPK1,
when incubated with HeLa cell nuclear extracts, blocks the
splicing of -globin gene (36).
The phosphorylation of PfSR1 RS domain by PfSRPK1 in-
hibits its ability to interact with RNA. It is likely that the at-
tenuation of RNA splicing by PfSRPK1 may be due to the de-
creased ability of phosphorylated PfSR1 to interact with the
RNA transcript. Alternatively, hyperphosphorylation of PfSR1
by PfSRPK1 may disrupt its interaction with other members
of the spliceosome assembly, which inhibits splicing by the
parasite extract. Once the architecture of Plasmodium spli-
ceosome and the identity of its components is clear, it will be
interesting to study their interaction with PfSRPK1/PfSR1.
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